Advertisement
The NYU Alcohol Study: Explaining the Most Important Addiction Trial
From NYU Langone Health on YouTube
·
17:00
·
Therapeutic Use
About This Video
The NYU psilocybin for alcohol use disorder trial produced striking results — 83% of participants showed significant reduction in drinking at 32-week follow-up. This video explains the design, results, and mechanism.
Key Takeaways
- 83% reduction or abstinence in drinking at 32 weeks
- Effect sizes exceed any existing pharmacotherapy for AUD
- Two psilocybin sessions produced lasting change
Advertisement